Works matching DE "GASTRIC inhibitory polypeptide"
Results: 408
Roche Says Investigational Once-Weekly "Twincretin" Shows Promise in Adults with Obesity in Early Stage Clinical Trial.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
O-02 Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy.
- Published in:
- JCEM Case Reports, 2024, v. 2, p. 1, doi. 10.1210/jcemcr/luad146.001
- By:
- Publication type:
- Article
How Effective are Gliflozins as DPP-4 Inhibitors? A Computational Study.
- Published in:
- Theoretical Foundations of Chemical Engineering, 2023, v. 57, n. 3, p. 403, doi. 10.1134/S0040579523030168
- By:
- Publication type:
- Article
Pharmacotherapy for the management of obesity.
- Published in:
- Medicine Today, 2023, v. 24, n. 3, p. 61
- By:
- Publication type:
- Article
Newer, Older, and Alternative Agents for the Eradication of Helicobacter pylori Infection: A Narrative Review.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 6, p. 946, doi. 10.3390/antibiotics12060946
- By:
- Publication type:
- Article
Decoding endocrine cell differentiation: insights from high‐throughput CRISPR screening in human gut organoids.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1526
- By:
- Publication type:
- Article
Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 3, doi. 10.1111/dom.14831
- By:
- Publication type:
- Article
Efficacy and safety of high‐dose glucagon‐like peptide‐1, glucagon‐like peptide‐1/glucose‐dependent insulinotropic peptide, and glucagon‐like peptide‐1/glucagon receptor agonists in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 788, doi. 10.1111/dom.14640
- By:
- Publication type:
- Article
Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 806, doi. 10.1111/dom.14636
- By:
- Publication type:
- Article
Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward‐ and attention‐related brain centres in response to visual food cues in adults with obesity: A cross‐sectional functional MRI study
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 5, p. 1202, doi. 10.1111/dom.14315
- By:
- Publication type:
- Article
Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 599, doi. 10.1111/dom.14258
- By:
- Publication type:
- Article
Effect of fully automated closed‐loop insulin delivery using faster aspart versus standard aspart on gluco‐regulatory hormones in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 228, doi. 10.1111/dom.14185
- By:
- Publication type:
- Article
The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2451, doi. 10.1111/dom.14174
- By:
- Publication type:
- Article
Incretin combination therapy for the treatment of non‐alcoholic steatohepatitis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1328, doi. 10.1111/dom.14035
- By:
- Publication type:
- Article
Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 6, p. 938, doi. 10.1111/dom.13979
- By:
- Publication type:
- Article
Incretin hormones: Their role in health and disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, p. 5, doi. 10.1111/dom.13129
- By:
- Publication type:
- Article
Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 4, p. 357, doi. 10.1111/dom.12227
- By:
- Publication type:
- Article
A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 1, p. 75, doi. 10.1111/dom.12181
- By:
- Publication type:
- Article
Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 8, p. 713, doi. 10.1111/dom.12082
- By:
- Publication type:
- Article
Comparison of independent and combined metabolic effects of chronic treatment with ( pGlu-Gln)- CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 7, p. 650, doi. 10.1111/dom.12079
- By:
- Publication type:
- Article
Liraglutide: short-lived effect on gastric emptying-long lasting effects on body weight.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 6, p. 531, doi. 10.1111/j.1463-1326.2012.01557.x
- By:
- Publication type:
- Article
Pharmacological mechanisms of hormone action in hypoglycemia: Maintaining glucose balance.
- Published in:
- African Journal of Diabetes Medicine, 2023, v. 31, n. 3, p. 1, doi. 10.54931/AJDM-31.3.8
- By:
- Publication type:
- Article
Neprilysin expression in pancreatic cells plays a protective role against pancreatic cell dysfunction.
- Published in:
- African Journal of Diabetes Medicine, 2023, v. 31, n. 2, p. 1
- By:
- Publication type:
- Article
Type 2 Diabetes patients and their Glucagonostatic potency (GLP-1).
- Published in:
- African Journal of Diabetes Medicine, 2021, v. 29, n. 5, p. 20
- By:
- Publication type:
- Article
TARGETING GASTROINTESTINAL TRACT IN TYPE 2 DIABETES.
- Published in:
- Medical Gazette / Medicinski Glasnik, 2018, v. 23, n. 70, p. 88
- By:
- Publication type:
- Article
GIP_HUMAN [22–51] Peptide Encoded by the Glucose-Dependent Insulinotropic Polypeptide (GIP) Gene Suppresses Insulin Expression and Secretion in INS-1E Cells and Rat Pancreatic Islets.
- Published in:
- Genes, 2023, v. 14, n. 10, p. 1910, doi. 10.3390/genes14101910
- By:
- Publication type:
- Article
Hippocampal Changes Elicited by Metabolic and Inflammatory Stressors following Prenatal Maternal Infection.
- Published in:
- Genes, 2023, v. 14, n. 1, p. 77, doi. 10.3390/genes14010077
- By:
- Publication type:
- Article
Non-altered incretin secretion in women with impaired fasting plasma glucose in the early stage of pregnancy: a case control study.
- Published in:
- Diabetology & Metabolic Syndrome, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13098-023-00981-7
- By:
- Publication type:
- Article
Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 8, p. 721, doi. 10.1080/17512433.2024.2363838
- By:
- Publication type:
- Article
Stevia rebaudiana Bertoni, an American plant used as sweetener: Study of its effects on body mass control and glycemia reduction in Wistar male and female rats.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0298251
- By:
- Publication type:
- Article
EFFECTS OF BIOAVAILABILITY OF MACRONUTRIENTS ON OVERALL CONTROL OF PLASMA GLUCOSE: A REVIEW.
- Published in:
- African Journal of Food, Agriculture, Nutrition & Development, 2023, v. 23, n. 10, p. 24844, doi. 10.18697/ajfand.125.23245
- By:
- Publication type:
- Article
Síndrome de Cushing independente de ACTH: Formas não Tumorigênicas em Dois Cães.
- Published in:
- Acta Scientiae Veterinariae, 2024, v. 52, p. s64, doi. 10.22456/1679-9216.143095
- By:
- Publication type:
- Article
Designer GLP1 poly-agonist peptides in the management of diabesity.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2023, v. 18, n. 3, p. 231, doi. 10.1080/17446651.2023.2204976
- By:
- Publication type:
- Article
Differences in GIP Receptor Expression by Feeding Status in the Mouse Brain.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 3, p. 1142, doi. 10.3390/ijms26031142
- By:
- Publication type:
- Article
Feline Diabetes Is Associated with Deficits in Markers of Insulin Signaling in Peripheral Tissues.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 23, p. 13195, doi. 10.3390/ijms252313195
- By:
- Publication type:
- Article
Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8650, doi. 10.3390/ijms25168650
- By:
- Publication type:
- Article
Divergent Effect of Central Incretin Receptors Inhibition in a Rat Model of Sporadic Alzheimer's Disease.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 1, p. 548, doi. 10.3390/ijms23010548
- By:
- Publication type:
- Article
GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1509, doi. 10.3390/ijms21041509
- By:
- Publication type:
- Article
Role of Disulfide Bonds in Activity and Stability of Tigerinin-1R.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 2, p. 288, doi. 10.3390/ijms19020288
- By:
- Publication type:
- Article
Understanding Insulin Endocrinology in Decapod Crustacea: Molecular Modelling Characterization of an Insulin-Binding Protein and Insulin-Like Peptides in the Eastern Spiny Lobster, Sagmariasus verreauxi.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 9, p. 1832, doi. 10.3390/ijms18091832
- By:
- Publication type:
- Article
Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 6, p. 920, doi. 10.3390/ijms17060920
- By:
- Publication type:
- Article
Transcriptional Analysis of Apoptotic Cerebellar Granule Neurons Following Rescue by Gastric Inhibitory Polypeptide.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 4, p. 5596, doi. 10.3390/ijms15045596
- By:
- Publication type:
- Article
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01412-5
- By:
- Publication type:
- Article
Tirzepatide.
- Published in:
- Australian Prescriber, 2023, v. 46, n. 4, p. 96, doi. 10.18773/austprescr.2023.028
- Publication type:
- Article
International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 9, doi. 10.1007/s10557-024-07630-9
- By:
- Publication type:
- Article
Vicenin‐2 inhibits the Helicobacterium pylori infection associated gastric carcinogenic events through modulation of PI3K/AKT and Nrf2 signaling in GES‐1 cells.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2021, v. 35, n. 3, p. 1, doi. 10.1002/jbt.22680
- By:
- Publication type:
- Article
Copurification of a Recombinant Modified Glucagon-Like and Glucose-Dependent Insulinotropic Peptide to Create a Two-Component Drug for the Treatment of Type 2 Diabetes Mellitus and Obesity.
- Published in:
- Applied Biochemistry & Microbiology, 2022, v. 58, n. 9, p. 976, doi. 10.1134/S0003683822090034
- By:
- Publication type:
- Article
Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5252, doi. 10.3390/jcm13175252
- By:
- Publication type:
- Article
Dipeptidyl-Peptidase-4 and Glucagon-like-Peptide-1, a Link in the Connection between Periodontitis and Diabetes Mellitus—What Do We Know So Far?—A Scoping Review.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 3, p. 903, doi. 10.3390/jcm13030903
- By:
- Publication type:
- Article
The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 14, p. 4575, doi. 10.3390/jcm12144575
- By:
- Publication type:
- Article